CME: Older Afib Patients Tolerate Anticoagulants
SPONSORED BY
University of Pennsylvania Perelman School of Medicine
MedPage Today
ACTIVE DATE
September 1, 2011 – September 1, 2012
CREDIT
Physicians: 0.25 AMA PRA Category 1 Credit(s)™
Family Physicians: 0.25 Elective credits
DESCRIPTION
A closely monitored cohort of elderly patients with atrial fibrillation who were anticoagulated with vitamin K antagonists appears to have experienced a very low bleeding rate, lending credence to the idea that they can be treated with stroke-preventing therapy, researchers said here.
LINK
for healthcare professionals
- Getting Started Home INR Monitoring
- Continuing Education
- CME: Chocolate Benefits Touted in Study
- CME: DVT Risk Starts Early, Stays Long After Stroke
- CME: Nationwide, Blacks Fare Worse Following Stroke
- CME: Older Afib Patients Tolerate Anticoagulants
- CME: Olive Oil Protects Against Stroke
- CME: Optimists May Have Fewer Strokes
- CME: The New Anticoagulants, a Stroke Prevention Clinical Context Report
- CME: Use of Warfarin in Afib Inconsistent
- CME: Warfarin Use Up, but Fewer Brain Bleeds
- CME: Stroke Risk in Afib Greater for Older Women
- CME: Cardiologists Urged to Lead in Smoking Cessation
- CME: New Tool Predicts Bleeding Tied to Warfarin Use
- Recent News
- WellLife Patient Education
